News

As part of an event marking the start of construction of a new Oligonucleotide Manufacturing Centre of Excellence , Scottish Enterprise and CPI have entered into an agreement to formalise a shared ambition to help Scotland be a place where companies in key technology sectors thrive.

The Bettii Pod Ltd, an innovative FemTech start-up founded by CEO Elaine Galston, has secured £70,000 in Scottish EDGE funding after emerging as a winner in the latest competition round

Today, Scotland’s First Minister, John Swinney, and the UK Minister of State for Science, Research and Innovation, Lord Vallance, marked the start of construction on the £20m Oligonucleotide Manufacturing Innovation Centre of Excellence in Glasgow City Region.

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) - the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners

The Scotland Food & Drink Partnership’s export programme, which pairs exporters with specialists in key markets and Scottish-based trade specialists, is celebrating its 10th anniversary, having supported over £1.7 billion in export growth since 2018 alone.

Technology that will significantly improve the safety of public water supplies by greatly improving the detection of waterborne pathogens, has been developed by scientists at Heriot-Watt University.

Tom Arthur MSP attends ceremony as winners take home £1.5 million in prize money

£2.3m investment led by St Andrews-based Eos Advisory, which included British Business Investments through their Regional Angels Programme, and existing investors Kelvin Capital and Scottish Enterprise.

Scottish Enterprise has supported Los Angeles based Launchpad Build Inc. to open a global Research and Development (R&D) hub in Edinburgh’s New Town

Eight companies have joined the Glasgow City Innovation District (GCID) Venture Studio Challenge pillar, looking to drive technological advancements in space data and sustainability solutions across various sectors.

Cytomos, an Edinburgh-based biotechnology company, has raised £5 million to scale up production of its unique cell analysis technology.

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.